Find Reports

Select Report Type

Reimbursement Review

Displaying 1026 - 1050 of 1422

Please scroll or swipe to the right to view the full content.

Title	Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date Sort ascending	Project Number
Agalsidase beta	Fabrazyme	Agalsidase beta	cdr_tracking_Fabrazyme_Resubmission.pdf cdr_complete_Fabrazyme_Resubmission_may2005.pdf	Fabry Disease	Do not list	Complete	Dec 10, 2004	May 18, 2005	SR0028-000
Voriconazole	VFEND	Voriconazole	cdr_tracking_Vfend_Resubmission.pdf cdr_complete_Voriconazole(Vfend)_April 14-05.pdf	Aspergillosis, Invasive	List with clinical criteria and/or conditions	Complete	Oct 25, 2004	Apr 14, 2005	SR0023-000
Cinacalcet hydrochloride	Sensipar	Cinacalcet hydrochloride	cdr_tracking_Sensipar.pdf cdr_complete_Cinacalcet(Sensipar)_mar23-05.pdf	Secondary hyper-parathyroidism in chronic kidney disease	Do not list	Complete	Aug 20, 2004	Mar 23, 2005	SR0018-000
Eletriptan hydrobromide	Relpax	Eletriptan hydrobromide	cdr_tracking_Relpax.pdf	Migraine	Do not list	Complete	Sep 21, 2004	Mar 23, 2005	SR0021-000
Adalimumab	Humira	Adalimumab	cdr_tracking_Humira.pdf cdr_complete_Humira(adalimumab)Feb11-05.pdf	Arthritis, Rheumatoid	List with clinical criteria and/or conditions	Complete	Sep 24, 2004	Feb 11, 2005	SR0022-000
Ciprofloxacin hydrochloride an...	Ciprodex	Ciprofloxacin hydrochloride and dexamethasone otic suspension	cdr_tracking_Ciprodex.pdf cdr_complete_Ciprodex_feb24-06.pdf	Otitis media with otorrhea & otitis externa, acute	Do not list	Complete	Jun 11, 2004	Jan 26, 2005	SR0014-000
Butoconazole nitrate	Gynazole.1	Butoconazole nitrate	cdr_tracking_Gynazole.1.pdf	Vaginal infection	Do not list	Complete	Jun 30, 2004	Jan 26, 2005	SR0017-000
Dutasteride	Avodart	Dutasteride	cdr_tracking_Avodart.pdf cdr_complete_Avodart_2005Jan24.pdf	Prostatic hyperplasia, benign	List in a similar manner to other drugs in class	Complete	Aug 24, 2004	Jan 20, 2005	SR0019-000
Teriparatide (rDNA origin) inj...	Forteo	Teriparatide (rDNA origin) injection	cdr_tracking_Forteo.pdf cdr_complete_Forteo_2004Dec22.pdf	Osteoporosis	Do not list	Complete	Jun 8, 2004	Dec 22, 2004	SR0015-000
Eprosartan mesylate/ hydrochlo...	Teveten Plus	Eprosartan mesylate/ hydrochlorothiazide		Hypertension, Essential	List in a similar manner to other drugs in class	Complete	Jul 8, 2004	Dec 15, 2004	SR0016-000
Agalsidase alfa	Replagal	Agalsidase alfa	cdr_tracking_replagal.pdf cdr_complete_Replagal_2004Nov24.pdf	Fabry Disease	Do not list	Complete	Feb 19, 2004	Nov 24, 2004	SR0006-000
Agalsidase beta	Fabrazyme	Agalsidase beta	cdr_tracking_Fabrazyme.pdf cdr_complete_Fabrazyme_2004Nov24.pdf	Fabry Disease	Do not list	Complete	Feb 24, 2004	Nov 24, 2004	SR0007-000
Mixed amphetamine salts	Adderall XR	Mixed amphetamine salts	cdr_tracking_Adderall.pdf cdr_complete_AdderallXR_2004Nov24.pdf	Attention deficit hyperactivity disorder	Do not list	Complete	Apr 13, 2004	Nov 24, 2004	SR0010-000
Miglustat	Zavesca	Miglustat	cdr_tracking_Zavesca.pdf cdr_complete_Zavesca_2004Nov24.pdf	Gaucher disease	Do not list	Complete	May 13, 2004	Nov 24, 2004	SR0012-000
Treprostinil sodium	Remodulin	Treprostinil sodium	cdr_tracking_Remodulin.pdf cdr_complete_Remodulin (treprostinil)_Nov17_04.pdf	Pulmonary arterial hypertension (NYHA Class III and IV patients)	Do not list	Complete	Jul 14, 2004	Nov 17, 2004	SR0011-000
Pegfilgrastim	Neulasta	Pegfilgrastim	cdr_tracking_neulasta.pdf cdr_complete_neulasta_10-27-04.pdf	Neutropenia	List with clinical criteria and/or conditions	Complete	Mar 29, 2004	Oct 27, 2004	SR0009-000
Peginterferon alfa-2a and Riba...	Pegasys RBV	Peginterferon alfa-2a and Ribavirin	cdr_complete_Pegasys_10_14_04.pdf	Hepatitis C, chronic	List in a similar manner to other drugs in class	Complete	May 14, 2004	Oct 14, 2004	SR0013-000
Tenofovir disoproxil fumarate	Viread	Tenofovir disoproxil fumarate	cdr_tracking_Viread.pdf cdr_complete_viread_08-25-04.pdf	HIV infection	Do not list	Complete	Feb 23, 2004	Aug 25, 2004	SR0008-000
Gefitinib	Iressa	Gefitinib	cdr_tracking_Iressa.pdf cdr_complete_iressa_06-23-04.pdf	Cancer, Lung , non-small cell	Do not list	Complete	Dec 22, 2003	Jun 23, 2004	SR0003-000
Norgelestromin/ethinyl estradi...	Evra	Norgelestromin/ethinyl estradiol	cdr_tracking_EVRA.pdf cdr_complete_Evra_06-23-04.pdf	Contraceptive, patch	Do not list	Complete	Dec 19, 2003	Jun 23, 2004	SR0004-000
Brimonidine tartrate/timolol m...	Combigan Ophthalmic Solution	Brimonidine tartrate/timolol maleate	cdr_tracking_Combigan.pdf cdr_complete_Combigan_05-27-04.pdf	Glaucoma	List with clinical criteria and/or conditions	Complete	Dec 15, 2003	May 27, 2004	SR0001-000
Atazanavir	Reyataz	Atazanavir	cdr_tracking_Reyataz.pdf cdr_complete_Reyataz_05-27-04.pdf	HIV infection	List in a similar manner to other drugs in class	Complete	Dec 16, 2003	May 27, 2004	SR0002-000
Almotriptan	Axert	Almotriptan	cdr_tracking_Axert.pdf cdr_complete_Axert_05-27-04.pdf	Migraine	List in a similar manner to other drugs in class	Complete	Dec 24, 2003	May 27, 2004	SR0005-000
Cabozantinib for Advanced Rena...	TBD	Cabozantinib				Withdrawn	Oct 6, 2017		PC0123-000
fluocinolone acetonide	Iluvien	fluocinolone acetonide		Diabetic macular edema (DME)		Withdrawn	Dec 21, 2017		SR0549-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 600 of 600

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1026 - 1050 of 2132

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
Interventions to Address and Prevent Violence Toward Health Care Workers in the Emergency Department	Interventions to Address and Prevent Violence Toward Health Care Workers in the…	Jun 24, 2021	Health Technology Review	Rapid Review	Active	RC1362
Hybrid Closed-Loop Insulin Delivery Systems for People with Type 1 Diabetes	OP0548 HCL Rec v. 7.0-pw.pdf op0548-hcl-consolidated-report-appendices-7.0.pdf de0104-hcl-insulin-scoping-brief-final.pdf op0548-hybrid-closed-loop-insulin-for-t1dm-update.pdf op0548-hybrid-close-loop-he-protocol-amendment-sep14.pdf	Jun 23, 2021	Health Technology Review	Optimal Use	Complete	OP0548-000
Laxatives and Erectile Dysfunction Medications to Treat Side Effects of Opioid Agonist and Methadone Maintenance Therapy	RC1364-OAT Final.pdf	Jun 22, 2021	Health Technology Review	Rapid Review	Completed	RC1364-000
Extracorporeal Membrane Oxygenation for Adults and Children with Severe Respiratory Failure: A Qualitative Rapid Review	Extracorporeal Membrane Oxygenation for Adults and Children with Severe Respira…	Jun 22, 2021	Health Technology Review	Rapid Review		RC1365-000
Smoke-Free Hospital Grounds	Smoke-Free Hospital Grounds	Jun 18, 2021	Health Technology Review	Policy Insight	Completed	CY0010-000
CADTH Pharmaceutical Reviews Update — Issue 24		Jun 17, 2021	Reimbursement Review	Pharmaceutical Review Update
Dabrafenib and Trametinib for Non-Small Cell Lung Cancer BRAF V600 Mutation	10226Dabrafenib-TrametinibNSCLC_inRec_pERC Chair Approved_Post01Apr2021_final.pdf Dabrafenib-Trametinib NSCLC BRAF V600 – pERC Final Recommandation Dabrafenib-Trametinib NSCLC BRAF V600 – Final Economic Guidance Report Dabrafenib-Trametinib NSCLC BRAF V600 – Final Clinical Guidance Report Dabrafenib-Trametinib NSCLC BRAF V600 – PAG Feedback on Initial Recommendation Dabrafenib-Trametinib NSCLC BRAF V600 – Manufacturer Feedback on Initial Recomm…Dabrafenib-Trametinib NSCLC BRAF V600 – Patient Advocacy Group Feedback on Init…Dabrafenib-Trametinib NSCLC BRAF V600 – Clinician Feedback on Initial Recommend…Dabrafenib-Trametinib NSCLC BRAF V600 – Patient Advocacy Group COI Declarations Dabrafenib-Trametinib NSCLC BRAF V600 – Clinician COI Declarations	Jun 16, 2021	Reimbursement Review		Complete	PC0226-000
satralizumab	SR0663 Enspryng - CDEC Final Recommendation April 23, 2021_for posting.pdf SR0663 Enspryng - Patient Input Group - For posting.pdf Clinical Review Report	Jun 15, 2021	Reimbursement Review		Complete	SR0663-000
Wearable Respiratory Sensor for the Detection of Opioid-Induced Respiratory Depression	EN0028 Respmeter Newsletter Final.pdf	Jun 15, 2021	Horizon Scan	Health Technology Update	Completed	EN0028-000
Artificial Intelligence and Machine Learning in Mental Health Services: A Literature Review	artificial_intelligence_and_machine_learning_in_mental_health_services_literature_review.pdf	Jun 14, 2021	Health Technology Review	Rapid Review	Completed	RC1194-000
Artificial Intelligence and Machine Learning in Mental Health Services: An Environmental Scan	artificial_intelligence_and_machine_learning_in_mental_health_services_environmental_scan.pdf	Jun 14, 2021	Health Technology Review	Environmental Scan	Completed	ES0343-000
Treatment Programs for Substance Use Disorder	Treatment Programs for Substance Use Disorder	Jun 8, 2021	Health Technology Review	Summary with Critical Appraisal	Completed	RC1360-000
Direct to Patient Virtual Visits	An Overview of Direct-to-Patient Virtual Visits in Canada	Jun 4, 2021	Horizon Scan	Emerging Health Technologies	Completed	EH0091-000
Conventional Disease-Modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis	RC1359 csDMARDs for the Treatment of RA Final.pdf	Jun 3, 2021	Health Technology Review	Rapid Review	Completed	RC1359-000
Abiraterone Acetate for Metastatic Castrate Sensitive Prostate Cancer	Abiraterone Acetate for Metastatic Castrate Sensitive Prostate Cancer	Jun 2, 2021	Health Technology Review	Peer-reviewed Summary with Critical Appraisal	Completed	RD0060-000
Bisphosphonate Drugs for the Treatment of Osteoporosis in Post-Menopausal Women	he0023-drugs-for-osteoporosis-protocol.pdf Drugs for the Treatment and Prevention of Osteoporosis in Postmenopausal Wome	Jun 1, 2021	Health Technology Review	Technology Review	Completed	HE0023-000
Evidence Update on Direct Oral Anticoagulants for Atrial Fibrillation	Direct Oral Anticoagulants for Atrial Fibrillation	May 27, 2021	Health Technology Review	Technology Review	Completed	HC0018-000
Single-Entry Models in Surgical Services	Single-Entry Models in Surgical Services (Policy Insight)	May 26, 2021	Health Technology Review	Policy Insight	Completed	CY0009-000
onasemnogene abeparvovec	Recommendation and Reasons Clinical Report Pharmacoeconomic Report Patient Group Input Submission Implementation Advice	May 26, 2021	Reimbursement Review		Complete	SG0649-000
Visual Examination Frequency for People Taking Ethambutol for Tuberculosis	Visual Examination Frequency for People Taking Ethambutol for Tuberculosis	May 25, 2021	Health Technology Review	Summary with Critical Appraisal	Completed	RC1343-000
Tuberculosis Screening for People with Chronic Conditions	Tuberculosis Screening for People with Chronic Conditions	May 13, 2021	Health Technology Review	Summary with Critical Appraisal	Completed	RC1345-000
Overview of Formulary Management Practices of Publicly Funded Provincial and Territorial Drug Plans	Overview of Formulary Management Practices of Publicly Funded Provincial and Te…	May 12, 2021	Health Technology Review	Environmental Scan	Completed	ES0354-000
Analysis of FPT Formulary Harmonization: Specialty Care Medications	Analysis of FPT Formulary Harmonization: Specialty Care Medications	May 12, 2021	Health Technology Review	Technology Review	Completed	HD0005-000
Framework for Drugs for Rare Diseases	es0355-drugs-for-rare-diseases-pw.pdf	May 6, 2021	Horizon Scan	Environmental Scan	Completed	ES0355-000
Electronic Aids to Daily Living	ES0346 Funding and Access to EADLs Final.pdf	May 6, 2021	Health Technology Review	Environmental Scan	Completed	ES0346-000